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APSS #3A: Medication errors

Executive summary checklist
Medication errors are major causes of inpatient harm and death. Medication errors are
preventable adverse events due to wrong medicine use including:
•
•
•
•
•
•

Wrong medicine
Wrong dose
Wrong route
Wrong time
Wrong patient
Wrong documentation of medicine

Ensure best patient care
 Create a multidisciplinary team to lead the project, including physicians, nurses,
pharmacists, and information technology personnel
 Use systematic protocols for medicine administration, including checklists for writing and
filling prescriptions, drug administration and patient transitions of care, and other quality
assurance tools including:
 Install the latest safety technology to prevent medication errors, such as:
 The BD Intelliport Medication Management System
 First Databank FDB MedKnowledge drug library system
 Other drug dosing solutions such as Monarch Medical Technologies solution for
calculating IV & SubQ insulin doses
 Use barcoding for identification in the medicine administration process
 Check patient’s allergy profile before prescribing medicine
 Ensure appropriate training and safe operation of automated infusion technologies
 Distinguish “look-alike, sound-alike” medicines by labeling, package design, and
storage
 Practice the Six Patient Rights on Medications - all care providers should use this simple
checklist: right patient, drug, dose, route, time of administration, and documentation
 Follow practices to prevent medication errors during Transitions of Care

Engage staff and use data to find areas for improvement
 Use technology to standardize Computerized Physician Order Entry (CPOE), reporting
systems and quality assurance reports to audit compliance
 Use Clinical Decision Support Systems (CDSS) where possible (Kane-Gill et al., 2017)
 Review monitoring and reporting results at medical staff meetings and education
sessions as a part of Continuous Quality Improvement (CQI)
 Use patient stories - in written and video form - to identify gaps and inspire change in
your staff
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What
about
medication
errors
Whatwe
weknow
know
about
medication
errors
Medication errors are a major cause of death. One out of every 2 surgeries has a medication
Medication
errors are a major cause of death. One out
error or an adverse drug event (Nanji et al., 2016). These errors have a global cost of about $42
billion
a year (Donaldson
et al., 2017).
of every
2 surgeries
has a medication error or an adAddressing medical errors can improve the quality and safety of healthcare and lower costs. It
verse
drug event (Nanji et al., 2016). These errors have
also helps create a safety culture, which is a culture that promotes patient safety and quality of
care
while reducing
preventable
risks and
harm.
a global
cost
of about
$42
billion a year (Donaldson et
Some types of medication errors are more common or severe. For example:
al., 2017).
• Drug infusion pump errors are common and may have serious consequences. Drug
Addressing
medical
errors
candesigned
improve
quality
infusion pumps
are complex and
have poorly
featuresthe
for the
user, which make
it difficult for the user to program and use. Patients who get infused medicines are often
and critically
safety
oftaking
healthcare
andwhich
lower
ill and
multiple medicines,
furthercosts.
increasesIt
thealso
chancehelps
of error
and adverse events.
create a safety culture, which is a culture that promotes
• Surgery has high rates of medication errors with a higher severity level (NQF, 2010). This
patient
and
qualityandoflackcare
while reducing
preis due safety
to a high-stress
environment
of computerized
order entry, pharmacy
approval, or second check by another person prior to giving the medicine.
ventable
risks and harm.
Preventing medication errors
Some
types of medication errors are more common or
To reduce medication errors, there are a variety of new approaches that hospitals and
healthcare
systems
can
commit to using, such as automated infusion and IV injectable
severe.
For
example:
technologies, electronic medical records, and checklists.
• Drug infusion pump errors are common and may
have serious plan
consequences. Drug infusion pumps are
Leadership
Hospital governance, senior administrative leadership, clinical leadership, and safety/risk
complex
and have poorly designed features for the
management leadership need to work collaboratively to reduce medication errors.
user, which make it difficult for the user to program
Show leadership’s commitment
and
use.a Patients
who
get
infused
medicines
aresafe
often
• Create
medicine safety
plan that
follows
the National
Quality Forum (NQF)
practices (NQF, 2010)
critically
ill and taking multiple medicines, which fur• Educate and empower patients, healthcare professionals, researchers, and insurers
theroincreases
thesochance
of and
error
and adverse
events.
Provide information
that leadership
all healthcare
professionals fully
understand the performance gaps in their own area of care
• Surgery
has high rates of medication errors with a
o Make sure all clinical/safety leadership endorse the plan to ensure it’s put into place
all providers
and systems
higheracross
severity
level
(NQF, 2010). This is due to a highCreate
infrastructure needed to make changes
stresstheen
•

•
•
•

Identify approaches to medication safety that:
o Have strong evidence that they work to reduce preventable deaths
o Can be applied in multiple care settings and for multiple patient types
Set a firm date to begin the safety plan, with measurable outcomes and milestones “Some is not a number. Soon is not a time.” (IHI, n.d.)
Get approval for the plan’s budget from governance boards and leadership
Use a standardized feedback system to fine-tune the plan over time
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Engage staff
•
•

Use patient stories – in written and video form – to teach and inspire change in your staff
For example, the story of Emily Jerry, daughter of Chris Jerry, is one of many compelling
stories that can be viewed and shared for free:
https://youtu.be/9jmULQ_m04o

Action plan
Provide staff training
•
•
•

Create a multidisciplinary team that includes physicians, nurses, pharmacists, and
information technology personnel
Assess opportunities to reduce medication errors using a self-assessment process (ISMP,
2011)
Create and deliver monthly or quarterly education on medication error and patient
safety updates

Create protocols
•

•

•
•
•
•

Create a universal checklist for medicine administration that includes:
o Patient name
o List of patient’s current medicines
o Medicine to be given and its:
• Dose
• Route
• Timing
• Documentation
Systematize tools and practices, including checklists, for:
o Patient allergy and medicine interaction checks on every patient
o CPOE (Computerized physician order entry)
o Medicine barcoding
o Patient education and adherence
o Correct and on-time medication administration (ISMP, 2011)
Practice hand hygiene when giving medicine as tablets, capsules, and pills by hand, such
as wearing gloves instead of bare hands
Use standardized order sets where possible
Review medicine labels and redesign as needed (Practices, n.d.)
Prepare medicine in separate, designated rooms to lower interruptions (HuckelsBaumgart et al., 2016)

Follow guidelines and regulations
•

Follow the Institute for Safe Medication Processes (ISMP) guidelines for
o Training and safe use of intravenous infusion pumps
o Use of medicine dispensing cabinets (ISMP, 2011)
o Adult IV Push Medications
o High-Alert Medications
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•

•
•
•

Ensure that all FDA and USP regulations are met and followed by either in-house
production or third party vendor as part of a standardized process for compounding
sterile medicines (Practices, n.d.)
Follow the APSS#4 guidelines for continuous monitoring of all patients who are receiving
parenteral narcotics or other sedative drugs
Practice CDC Guidelines for single use injections - one solution, one patient, one syringe
Use FDA Manufactured Single Use Injection Kits (SUIK) when available

Ensure safety during transitions of care
•

•

•

•
•

Consider the following high-risk medicine groups:
1. Opioids
a. Consider all pain medicines including over the counter
b. Concern for over-using tylenol
2. Anti-diabetics
a. Resume Metformin, confirm kidney function appropriate
b. Adjust insulin based on food intake
3. Anticoagulation/Antiplatelet
a. INR levels, renal function, OTC medicine use (NSAIDs)
4. Antibiotics
a. Appropriate duration of therapy
b. Labs ordered (vancomycin follow up)
c. Home health ordered
Coordinate appropriate follow up and monitoring, such as:
o Labs: INR, Digoxin levels, electrolytes, blood sugar, vancomycin troughs, thyroid
levels
o Chronic disease state management, such as heart failure, asthma, and COPD
Confirm medicine dose for any changes in health status, including changes in:
o Weight
o Renal and liver function
o Functions that could affect the patient’s ability to take medicine by mouth, injection,
or inhalation
Confirm needed medical equipment is ordered, such as a nebulizer, diabetic supplies,
and IV antibiotic
Evaluate for high risk disease states
o Check patients comply with core measures and immunizations when appropriate
(Stroke, MI, Heart Failure)
o Ensure patients receive and are educated on scheduled vaccines (influenza,
pneumonia, etc)
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Technology plan
These suggested practices and technologies have shown proven benefit or, in some cases,
are the only known technologies for certain tasks. If you know of other options not listed here,
please complete the form for the PSMF Technology Vetting Workgroup to consider:
https://patientsafetymovement.org/actionable-solutions/apss-workgroups/technologyvetting/

System or practice

Available technology

All settings
ONC Meaningful Use Cert ified EHR system
Electronic Health Record (EHR) System with
the following capabilities:
•

Computerized Physician Order Entry
(CPOE)

•

Drug-drug interaction check

•

Drug-allergy interaction check

•

Electronic Prescribing (eRx)

•

Electronic Prior Authorization (ePA)

Electronic Medication Administration Record
(eMAR) system with pharmacy and bedside
barcoding capabilities

First Databank FDB MedKnowledge system
(First Databank, 2014)

FDA approved clinical decision support
solution for medication therapy
recommendation

Monarch Medical Technologies* Endotool
Solutions for insulin

Infusion pumps that wirelessly communicate
data back to the electronic eMAR
Patient and medication barcoding system
CPOE simulation tool to quantify the risk of
serious ADEs with your current system CPOE
(Metzger et al., 2010; Leung et al., 2013)

Leapfrog CPOE Evaluation Tool (Leapfrog,
2016)

Drug libraries
Pharmacy workflow manager
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DoseEdge from Baxter Healthcare

Surgery environment
IV injectable doses, audible and visual
BD Intelliport* Medication Management
feedback for each syringe attached with
System.
measurement of dose, allergy alerts and more
accurate and timely documentation wireless
to the anesthesia information system

Continuous physiologic monitoring on
patients receiving IV medications to provide
an early indication of deterioration due to a
medication error

Masimo* rainbow Acoustic Monitoring
(Mimoz et al., 2012)

Pharmacy
Pharmacy robots to reduce safety problems
associated with providers drawing up their
own medications, and risks associated
with contamination from outsourced
compounders

BAXA Intellifil Robot

Utilize single use injection kits or pre-mixed
sterile solutions

•

Asclemed USA Inc., Injection Kits

•

Nubratori RX, Pre-mixed sterile solutions

Other considerations
“End-to-end” smart pump system, or other electronic pump systems
*Company has signed some form of the Open Data Pledge, more information can be found on
the Patient Safety Movement Foundation website: https://patientsafetymovement.org/partners/
open-data-pledges/view-all-open-data- pledges/

Measuring outcomes
Key performance indicators
Adverse drug event: Adverse drug event (ADE) with harm to patient (Category E or higher
on NCC-MERP classification) that is preventable (i.e., not an unknown first-time reaction to a
medicine).

Outcome measure formula
Numerator: Number of reported adverse drug events with harm (as defined above) – by class
or medication
Denominator: Number of doses administered (by medicine or class of medicines)
*Rate is typically displayed as ADE with harm/1000 doses given
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Metric recommendations
Indirect impact (preventable rate): All patients
Direct impact (non-preventable rate): All patients prescribed medicines
Lives spared harm:
Lives Spared Harm = (ADE Rate baseline - ADE Rate measurement ) X Doses or Adjusted Patient Days
baseline

Lives saved:
Lives Saved = Lives Spared Harm x Mortality Rate

Notes
Top medicine classes and triggers:
1. Opioids
2. Sedatives and hypnotics (including propofol)
3. Anticoagulants
4. Antimicrobials (including antivirals and antifungals)
5. Anti-diabetic medicines (including insulin, and other injectable and oral medicines)
6. Injectable medicines
Initial or baseline measurement will show ability to capture ADE information, since most
are voluntarily reported. Over time, decreases in this rate can show lives spared harm. To
ensure that reductions are not due to decreased reporting, a control measure should also be
measured:

Control rate calculation
Numerator: Number of ALL reported errors and adverse drug reactions (including harm and
NOT causing harm or “near misses”)
Denominator: Number of doses administered over time period
Control ADE rate should be consistent or increase, with corresponding decrease in ADE with
harm.

Data collection
ADE reporting information is based on volunteer reporting and accuracy of people verifying
reports (preferably from pharmacy and a medication errors reporting program, MERP).
Medicine usage information is usually collected from billing information rather than medicine
orders (more accurate if patient received the dose or not).
If medicine usage information is not available, denominator could be per 1000 patient days.
This can track over time, especially for all ADE reporting, however, will not adjust ADE rate for
high or low utilization medications.
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Scales
•

The Adverse Drug Reaction Probability Scale (Naranjo) determines the causality of an
ADR or how likely is the drug the true cause of the ADE (NLM, 2015)

Mortality (will be calculated by the Patient Safety Movement Foundation)
The PSMF, when available, will use the mortality rates associated with Hospital Acquired
Conditions targeted in the Partnership for Patients (PfP) grant funded Hospital Engagement
Networks (HEN).
The program targeted 10 hospital acquired conditions to reduce medical harm and costs of
care. “At the outset of the PfP initiative, HHS agencies contributed their expertise to developing
a measurement strategy to track national progress in patient safety—both in general and
specifically related to the preventable HACs being addressed by the PfP. Along with CMS’s
overall leadership of the PfP, AHRQ has helped coordinate development and use of the
national measurement strategy. The results using this national measurement strategy have been
referred to as the “AHRQ National Scorecard,” which provides summary data on the national
HAC rate (AHRQ, 2015). Adverse drug events was included in this work with published metric
specifications. This is the most current and comprehensive study to date.
Based on these data the estimated additional inpatient mortality for Adverse Drug Events is
0.020 (20 per 1000 events).

Conflicts of interest disclosure
The Patient Safety Movement Foundation partners with as many stakeholders as possible to
focus on how to address patient safety challenges. The recommendations in the APSS are
developed by workgroups that may include patient safety experts, healthcare technology
professionals, hospital leaders, patient advocates, and medical technology industry volunteers.
Some of the APSS recommend technologies offered by companies involved in the Patient
Safety Movement Foundation that the workgroups have concluded, based on available
evidence, that these technologies work to address APSS patient safety issues. Workgroup
members are required to disclose any potential conflicts of interest.

Workgroup
Co-Chairs
Ron Jordan

Chapman University School of Pharmacy

Jerika Lam

Chapman University School of Pharmacy

Members
This list represents all contributors to this document since inception of the Actionable Patient
Safety Solutions.
Peter Antevy

Handtevy

Steven Barker

Patient Safety Movement Foundation;Masimo

*Linda Beneze

Monarch Medical Technologies

Michel Bennett

Patient Safety Movement Foundation
APSS #3A | 9

Laressa Bethishou

Chapman University School of Pharmacy

Jim Broselow

eBroselow

John Burnam

Louise H. Batz Patient Safety Foundation

Mitchell Goldstein

Loma Linda Medical Center

Kari Hamlin

Hackensack Medical Center

Helen Haskell

Mothers Against Medical Error

Christopher Jerry

The Emily Jerry Foundation

Edwin Loftin

Parrish Medical Center

Ariana Longley

PatientSafetyMovementFoundation

Jacob Lopez

Patient Safety MovementFoundation

Anne Lyren

Children’s Hospitals’ Solutions for Patient Safety

Brendan Miney

Talis Clinical

Sidney Morice

Lee Health

Steve Mullenix

National Council for Prescription Drug Programs

Robert Nickell

Enovachem

Rochelle Sandell

Patient Advocate

David Shane Lowry

Rosalind Franklin University of Medicine and Science

Robin Shannon

The T System

Deeba Siddiqui

Hackensack Medical Center

Charles Simmons

Cedars-Sinai Medical Center

Nat Sims

Massachusetts General Hospital

Robert Stein

Keck Graduate Institute

Laura Townsend

Louise H. Batz Patient Safety Foundation

Jason Yamaki

Chapman University School of Pharmacy

Sun Yang

Chapman University School of Pharmacy

Metrics integrity
Robin Betts

Kaiser Permanente, Northern California Region

*This Workgroup member has reported a financial interest in an organization that provides a
medical product or technology recommended in the Technology Plan for this APSS.

10 | APSS #3A

References
(2011). APsF Newsletter, 26, 21–26.
Donaldson, L. J., Kelley, E. T., Dhingra-Kumar, N., Kieny, M.-P. and Sheikh, A. (2017). Medication
Without Harm: WHOs Third Global Patient Safety Challenge. The Lancet, 389(10080), 1680–
1681.doi:10.1016/s0140-6736(17)31047-4
First Databank. (2014) Case Study: Enterprise EMAR, hospital [Pharmacy, Barcoding Meta
Healthcare IT Solutions. Retrieved from: http://www.fdbhealth.com/~/media/downloads/
form%20required/us/case%20study%20-%20fdb%20medknowledge%20-%20
barcoding%20-%20meta%20healthcare.ashx
Huckels-Baumgart, S., Baumgart, A., Buschmann, U., Schüpfer, G. and Manser, T. (2016).
Separate Medication
Preparation Rooms Reduce Interruptions and Medication Errors in the Hospital Setting: A
Prospective Observational Study. J Patient Saf.
Institute for Healthcare Improvement. Overview of the 100,000 lives campaign. Retrieved from:
https://www.ihi.org/Engage/Initiatives/Completed/5MillionLivesCampaign/Documents/
Overview%20of%20the%20100K%20Campaign.pdf
ISMP. (2011). ISMP Acute Care Guidelines for Timely Administration of Scheduled Medications.
ISMP. ISMP Guidelines for Safe Preparation of Compounded Sterile Preparations.
ISMP. ISMP’s Guidelines for Standard Order Sets. ISMP. Institute for Safe Medication Practices.
ISMP. Institute for Safe Medication Practices. Institute for Safe Medication Practices (ISMP)
Guidance on Automated Dispensing Cabinets.
ISMP. (2011). 2011 ISMP Medication Safety Self Assessment for Hospitals.
ISMP. Proceedings from the ISMP Summit on the Use of Smart Infusion Pumps: Guidelines for
Safe Implementation and Use.
Kane-Gill, S. L., Dasta, J. F., Buckley, M. S., Devabhakthuni, S., Liu, M., Cohen, H., … Smith, B. S.
(2017).
Clinical Practice Guideline: Safe Medication Use in the ICU.. Crit Care Med, 45, e877–e915.
Kerr, E. (2000). What is an Error?. Effective Clinical Practice, 6.
Nanji, K. C., Patel, A., Shaikh, S., Seger, D. L. and Bates, D. W. (2016). Evaluation of Perioperative
Medication Errors and Adverse Drug Events. Anesthesiology, 124(1), 25–34. doi:10.1097/
aln.0000000000000904
The Leapfrog Group. (2016). Prepare for CPOE Tool. Retrieved from: http://www.leapfroggroup.
org/survey-materials/prepare-cpoe-tool
Leung, A. A., Keohane, C., Lipsitz, S., Zimlichman, E., Amato, M., Simon, S. R., ... & Seger, D. L.
(2013).
Relationship Between Medication Event Rates and the Leapfrog Computerized Physician Order
Entry Evaluation Tool. Journal of the American Medical Informatics Association, 20(e1),
e85-e90.
Medicine, U. S. N. L. of. (2015). Adverse Drug Reaction Probability Scale (Naranjo) in Drug
Induced Liver Injury.Retrieved from https://livertox.nih.gov/Narajo.html
APSS #3A | 11

Metzger, J., Welebob, E., Bates, D. W., Lipsitz, S., & Classen, D. C. (2010). Mixed Results in the
Safety Performance of Computerized Physician Order Entry. Health Affairs, 29(4), 655-663.
Mimoz, O., Benard, T., Gaucher, A., Frasca, D., & Debaene, B. (2012). Accuracy of Respiratory
Rate Monitoring Using a Non-invasive Acoustic Method After General Anaesthesia. British
Journal of Anaesthesia, 108(5), 872-875.
Palmieri, P. A., DeLucia, P. R., Peterson, L. T., Ott, T. E. and Green, A. The Anatomy and Physiology
of Error in Adverse Health Care Events. In Advances in Health Care Management (pp. 33–68).
Emerald (MCB UP ). doi:10.1016/s1474-8231(08)07003-1
Quality, A. for H. R. and. (2015). Efforts to Improve Patient Safety Result in 1.3 Million Fewer
Patient Harms. Retrieved from http://www.ahrq.gov/professionals/quality-patient-safety/pfp/
interimhacrate2013.html
(2010). Washington, DC, National Quality Forum.

12 | APSS #3A

APSS #3A | 13

